Detection of anti-cyclic citrullinated peptide antibody in patients with psoriatic arthritis disease and its significance

Pan Hong,Li Ming
DOI: https://doi.org/10.3969/j.issn.1004-0188.2013.05.016
2013-01-01
Abstract:Objective To study the clinical significance of anti-cyclic citrullinated peptide antibody(anti-CCP)in patients with psoriatic arthritis(PsA),and to explore the correlation between anti-CCP and the complicated arthritis and bone erosion and also the significance of anti-CCP in the judgment of prognosis.Methods Enzyme linked immunosorbent assay was used to detect the anti-CCP level in the serum of 56 patients with PsA.The correlation between anti-CCP and the clinical features of those patients was analyzed.Results The positive rate of anti-CCP in patients with PsA was 12.5 %(7/56).The positive rate of anti-CCP in the five clinical classification of PsA was 7.1%,21.4%,0%,0%,0%,respectively.The positive rate of anti-CCP in symmetry polyarthritis PsA was significantly higher that those in the other four kinds of PsA(P<0.05).The comparison of laboratory indexes between PsA patients with positive and negative anti-CCP antibody indicated that the number of patients with peripherial arthrocele,the wrist joint involvement scale,and erythrocyte sedimentation rate(ESR)in the group with positive anti-CCP antibody were all higher than those in the group with negative anti-CCP antibody(P<0.05).There was no significant difference in the age of onset,the course of arthritis,positive family medical history,elbow joint involvement,sausage-like toe,lumbosacral pain,and C reactive protein(CRP)between the two groups.Conclusion Anti-CCP antibody exists in 12.5% of the patients with PsA.There is a close correlation between the occurrence of the anti-CCP antibody and the incidence of polyarticular arthritis and the erosion of bone in patients with PsA,which has an important clinical value in the prognosis judgment of PsA arthritis.
What problem does this paper attempt to address?